Neil Charter

Title: Inventor Spotlight: Neil Charter

Introduction

Neil Charter, an accomplished inventor based in Newark, California, holds a significant patent that showcases his contributions to biochemical assays. His innovative approaches have the potential to enhance the accuracy of detecting adenosine diphosphate (ADP), a critical molecule in cellular energy metabolism.

Latest Patents

Neil's patent titled "ADP detection using an enzyme-coupled reaction" introduces methods and compositions for determining ADP in the presence of adenosine triphosphate (ATP). The methodology involves utilizing various assay reagents, including creatine phosphokinase, phosphocreatine, pyruvate kinase, phosphoenolpyruvate, peroxidase, and a non-interfering peroxidase substrate. One of the highlighted aspects of his innovation is the formation of hydrogen peroxide from ADP through the action of pyruvate kinase, phosphoenolpyruvate, and pyruvate oxidase. This hydrogen peroxide is subsequently measured, offering a precise quantification method for ADP.

Career Highlights

Neil Charter is associated with DiscoverX Corporation, where he contributes to advancements in bioanalytical technologies. His expertise and groundbreaking work in enzymatic assays underscore the company's commitment to delivering innovative solutions in the life sciences industry.

Collaborations

Throughout his career, Neil has collaborated with esteemed professionals such as Richard M. Eglen and Rajendra Singh. These partnerships reflect the collaborative spirit prevalent in the scientific community and highlight the synergy that drives innovation in pharmaceutical and biotechnology fields.

Conclusion

In summary, Neil Charter's contributions to the field of biochemical detection through his patent exemplify the impact of innovative thinking in science and technology. His work continues to inspire future advancements, making significant strides in understanding and measuring essential biomolecules.